These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9862759

  • 1. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
    Raap DK, Evans S, Garcia F, Li Q, Muma NA, Wolf WA, Battaglia G, Van De Kar LD.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
    [Abstract] [Full Text] [Related]

  • 2. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK, Garcia F, Muma NA, Wolf WA, Battaglia G, van de Kar LD.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [Abstract] [Full Text] [Related]

  • 3. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
    Li Q, Muma NA, van de Kar LD.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van de Kar LD.
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [Abstract] [Full Text] [Related]

  • 5. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD.
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [Abstract] [Full Text] [Related]

  • 6. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors.
    Li Q, Muma NA, Battaglia G, Van de Kar LD.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1581-90. PubMed ID: 9316875
    [Abstract] [Full Text] [Related]

  • 7. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD, Raap DK, Battaglia G, Muma NA, Garcia F, DonCarlos LL.
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [Abstract] [Full Text] [Related]

  • 8. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine.
    Li Q, Battaglia G, Van de Kar LD.
    Brain Res; 1997 Sep 19; 769(1):141-51. PubMed ID: 9374282
    [Abstract] [Full Text] [Related]

  • 9. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F, Muma NA, Raap DK, Garcia F, Battaglia G, Van de Kar LD.
    J Pharmacol Exp Ther; 2000 Jul 19; 294(1):296-301. PubMed ID: 10871325
    [Abstract] [Full Text] [Related]

  • 10. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD, Li Q, Cabrera TM, Brownfield MS, Battaglia G.
    J Pharmacol Exp Ther; 1998 Jul 19; 286(1):256-62. PubMed ID: 9655867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN, Zhang Y, Damjanoska KJ, Carrasco GA, Sullivan NR, Garcia F, Battaglia G, Doncarlos LL, Muma NA, Van de Kar LD.
    Neuroendocrinology; 2004 Jul 19; 80(1):31-41. PubMed ID: 15385710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
    Castro M, Diaz A, del Olmo E, Pazos A.
    Neuropharmacology; 2003 Jan 19; 44(1):93-101. PubMed ID: 12559126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R, Bramante M, Samanin R.
    Pharmacol Biochem Behav; 1996 May 19; 54(1):143-7. PubMed ID: 8728551
    [Abstract] [Full Text] [Related]

  • 18. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

  • 19. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
    Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD.
    Brain Res; 1993 Dec 10; 630(1-2):148-56. PubMed ID: 8118681
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A receptor-mediated activation of neuroendocrine responses and multiple protein kinase pathways in the peripubertal rat hypothalamus.
    Petrunich-Rutherford ML, Garcia F, Battaglia G.
    Neuropharmacology; 2018 Sep 01; 139():173-181. PubMed ID: 30005975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.